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INTRODUCTION
Lymphangiomyomatosis (LAM) is a rare disease of a hamar-
tomatous nature characterized by proliferation of abnormal
lymphatic smooth muscle cells. Smooth muscle cells are often
classified in the family of perivascular epithelioid cells (PEC).
Some of these cells include renal angiomyolipoma, sugar tumor
of the lung and pancreas, and clear-cell myomelanocytic tumor
of the falciform ligament. These so-called “PECom” all express
HMB-45 (1). The primary site of origin is the lung and occur-
rence is usually associated with decreased pulmonary function
and chylous effusions (2). The outcome of this disease can be
devastating but the underlying etiology and effective treat-
ments are unknown. Extrapulmonary LAM is quite rare and
mainly located in the pelvis and retroperitoneum, along the
lymphatic channels. The clinical features are the presence of
chylous ascites, a palpable abdominal mass, and abdominal
pain (3). We report a case of a young female who was initially
diagnosed with retroperitoneal LAM that eventually led to
pulmonary involvement with decreased lung function.
CASE REPORT 
A 21-yr-old female patient presented with a sudden onset
of low abdominal pain. With the clinical impression of an
ovarian cyst, she was transferred from a local GYN clinic to
our hospital. Gynecologic ultrasonography revealed a large pos-
terior pelvic mass with an irregular echogenicity measuring 9.7
×4.2 cm in size (Fig. 1). The patient had no specific past med-
ical history with a parity of 0-0-0-0. A considerable amount
of fluid was present in the cul de sac. The uterus and both ad-
nexae were unremarkable. There was no ultrasonographic evi-
dence of lymphadenopathy. Pelviscopy showed a large, thin
walled, partly cystic, pelvic mass measuring approximately 10 cm
in diameter. The mass was adherent to the internal and exter-
nal iliac vessels and the right pelvic wall. It was not possible to
remove the tumor completely. The retroperitoneal mass was
partly removed by pelviscopy and samples were submitted
for frozen section analysis.
Pathologic findings
The submitted specimen for frozen section analysis consisted
of multiple irregular fragments of soft tissue weighing approx-
imately 30 g. The tumor was soft and grayish-tan with focal
areas of hemorrhage (Fig. 2). On frozen section, the possibility
of epithelioid smooth muscle tumor or paraganglioma was
suspected. Microscopically, the masses were characterized by
a haphazard proliferation of smooth muscle cells (LAM cells)
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Lymphangioleiomyomatosis (LAM) is a rare disease usually occurring in young wo-
men of child-bearing age. It is characterized by a distinctive proliferation of lymphatic
smooth muscle cells, especially occurring in the pulmonary parenchyme. The majority
of primary LAM occurs in the lung, but there are a few reports of extrapulmonary
cases. We report a case of a 21-yr-old female who first complained of low abdominal
pain and was referred from a local clinic with the impression of an ovarian cyst. Gyne-
cologic ultrasonography revealed a large posterior pelvic mass with an irregular echo-
genicity measuring 9.7×4.2 cm in size. Pelviscopy showed a large, thin walled, partly
cystic, pelvic mass. The mass was partly removed. Microscopically, the mass was
characterized by a haphazard proliferation of smooth muscle cells arranged in fas-
cicular, trabecular, and papillary patterns around a ramifying network of endotheli-
um-lined spaces. The cells were plump or epithelioid with abundant eosinophilic cyto-
plasm and showed a positive reaction for both alpha-smooth muscle actin and HMB-
45 antigen. Surgical and pathological findings were consistent with pelvic retroperi-
toneal LAM. Despite the numerous treatment attempts, the patient suffered from in-
tractable chylous ascites and developed pulmonary LAM and died due to severe respi-
ratory distress.
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arranged in fascicular, trabecular, and papillary patterns around
a ramifying network of endothelium-lined spaces. The cells
were plump or epithelioid with abundant eosinophilic cyto-
plasm and bland nuclei with no mitotic activity. These cells
invaded into fat tissue surrounding the lesion. The vascular
spaces were empty or sometimes filled with eosinophilic mate-
rial (Fig. 3). Aggregations of lymphocytes were between the
LAM cells, representing vestiges of preexisting lymph nodes
(Fig. 4). Occasional foci of hemorrhage and necrosis were pre-
sent.
Most of the LAM cells showed a positive reaction for alpha-
smooth muscle actin (Dako Co., Carpinteria, CA, U.S.A.), vi-
mentin (Zymed, San Francisco, CA, U.S.A.), desmin (Bio-
Genex, San Ramon, CA, U.S.A.), and HMB-45 (Dako) (Fig.
5). S-100 protein (DiNonA Inc. Seoul, Korea), cytokeratin
(Dako), chromogranin (Zymed), and CD 34 (Immunotec,
Fig. 3. The tumor cells proliferate in papillary patterns, with lymphoid
aggregates and some cystic spaces filled with eosinophilic material
(arrow) (H&E, ×100).
Fig. 4. The epithelioid lymphangioleiomyomatous cells proliferate
haphazardly around slit-like vascular channels, with aggregation
of lymphoid cells (arrow) (H&E, ×400).
Fig. 2. The submitted specimen consists of multiple irregular frag-
ments of soft tissue.
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Fig. 1. Pelvic ultrasonogram shows a large posterior pelvic mass
with an irregular echogenicity (arrow) measuring 9.7×4.2 cm.906 H.-S. Kim, M.-I. Park, K.-S. Suh
Marseille, Cedex, France) were negative. Estrogen (Immunotec)
and progesterone (Novocastra Lab. Ltd. Newcastle, U.K.) re-
ceptors were observed in only 10% of the LAM cells. Ki-67
(Zymed) was positive in less than 5% of the tumor cells. Clin-
ical evidence of tuberous sclerosis was not present. Evaluation
for the TSC gene was not performed.
Clinical course
After operation, the patient had continuous oozing of chy-
lous ascitic fluid of approximately 1,500 to 2,000 mL per day.
There was no clinical or radiological evidence of pulmonary
involvement at the time of the initial diagnosis. Chylous pleu-
ral effusion was also identified two months after the operation.
Chest CT scans showed diffuse, small, thin walled cystic le-
sions in both lung parenchymas with pleural effusion (Fig. 6).
The patient was treated with tamoxifen and medroxyproges-
terone, but the response was limited. Even after chest tube
insertion and pleurodesis, she continued to drain approximate-
ly 800 to 2,300 mL of chylous fluid per day. In the terminal
stages of the disease, the patient suffered severe respiratory
distress and died six months after initial operation.
DISCUSSION
Zamboni et al. (1) described a group comprising sugar tu-
mor, angiomyolipoma, and lymphangiomyoma as a special
family of tumors. The nature of perivascular proliferation of
abnormal smooth muscle cells and common antigenic expres-
sion of HMB-45, a melanosomal antigen, leads to the concept
of so-called perivascular epitheloid cells-PEComa.
HMB-45 positive cells are found in both LAM and angio-
myolipoma; however, angiomyolipomas are characterized by
the presence of abundant adipose tissue and by disorganized
components of blood vessels (4). The incidence of angiomyo-
lipomas in patients with LAM has been reported to be as high
as 60% (2). Matsui et al. (3) regarded angiomyolipomas as an
unusual but distinct expression of the proliferative capacity
of LAM cells. Most of the tumor cells in this case showed a
positive reaction for HMB-45. Accumulation of fat tissue
within the lesion was not prominent in this case.
LAM is a tumor of the lymphatic channels and lymph nodes
clinically manifested by recurrent chylous pleural effusions and
ascites. The disease is usually progressive and unresponsive to
surgery, chemotherapy, or irradiation. LAM of the lungs is
characterized microscopically by abnormal smooth muscle pro-
liferation causing gradual obstruction of small airways, lym-
phatics, and vasculature (5). The typical presenting symptoms
include dyspnea (83%) and pneumothorax (69%) (2). 
Extrapulmonary LAM is rare. Recently, Jaiswal et al. (6)
reviewed 32 extrapulmonary LAM cases, including 22 cases
of extrapulmonary LAM reported by Matsui et al. (3). Among
the reported cases of clinically significant extrapulmonary
LAM, 14 cases occurred in the lower retroperitoneum or pelvic
cavity (3, 4, 6). Most extrapulmonary LAM lesions occurred
in lymph nodes along the lymphatic vessels of the posterior
mediastinum, retroperitoneum, and the pelvic cavity. The di-
agnosis of extrapulmonary LAM preceded that of pulmonary
LAM in 13 of 17 patients for whom follow-up data were avail-
able (3). In this case, extrapulmonary manifestations preceded
chylous pleural effusion. Our patient presented with a sudden
onset of low abdominal pain. In Korea, approximately 24 cases
of LAM have been reported in the current literature, all with
Fig. 5. The perivascular epithelioid cells express strong cytoplasmic
positivity for HMB-45 (×200).
Fig. 6. A chest CT scan shows diffuse small thin walled cystic le-
sions in both lung parenchymas with pleural effusion (arrow).Lymphangiomyomatosis in the Pelvic Cavity 907
a primary site in the lungs (7-9). This case is, to our knowl-
edge, the first extrapulmonary LAM reported in Korea.
The origin and cause of this disease are yet to be undeter-
mined however there are some common peculiar aspects. LAM
can be divided into a sporadic form, as in this case, or a tuber-
ous sclerosis-associated form (10-12). There have been many
studies regarding the genetic predisposition of LAM, especially
associated with the mutation of tuberous sclerosis genes (TSC1
and TSC2) (12, 13). This condition is usually defined as tuber-
ous sclerosis complex (TSC). TSC is an autosomal dominant
disorder and is manifested as seizures, mental retardation, au-
tism, and hamartomatous tumors of the brain, heart, kidney,
lung, and skin. These tumors include cerebral cortical tumors,
subependymal giant cell astrocytomas, retinal hamartomas,
cardiac rhabdomyomas, renal angiomyolipomas, and facial
angiofibromas (13). Four of the 32 extrapulmonary LAM cases
were associated with tuberous sclerosis (6). There was no clin-
ical evidence of TSC in this case.
The speculation that LAM is a female sex hormone depen-
dent tumor is supported by the high prevalence rate in women
of reproductive age and exacerbation of the disease by preg-
nancy or by administration of estrogen. Numerous studies and
case reports regarding clinical trials of hormonal therapy had
been reported (14, 15). However, the role of estrogen and pro-
gesterone receptors in proliferation of smooth muscle and the
therapeutic efficacy of hormone therapy are not well establi-
shed. Our patient was treated with tamoxifen and medroxy-
progesterone, but her response was limited.
Despite a variety of treatment regimens developed since
the first description of LAM, patient survival has not improved
appreciably. LAM progresses slowly and most patients die
within 10 yr of diagnosis (16). Despite the slow progression
rate of other LAM cases, our patient died of the disease six
months after operation. The reason for her rapid progression
is not clear. Prolonged chylous peritoneal and pleural effusions,
aggressive deterioration of pulmonary function, and her lack
of response to various treatment modalities were major con-
tributing factor.
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